About Quanticel

About Quanticel

The Quanticel team combines a veteran management team, leading academics from Stanford University, and astute VC investors from Versant Ventures.

Learn More

Science and Technology

Science and Technology

Quanticel's proprietary platform for single-cell genomic analysis of tumors supports the discovery of first-in-class oncology drug candidates.

Learn More

News

News

Celgene to Acquire Quanticel Pharmaceuticals - Celgene Committed to Expanding Sustainable Pipeline of Life-Enhancing Medical Innovation to Benefit Cancer Patients

Learn More

Careers

Careers

Quanticel is currently hiring exceptional researchers and technical experts committed to advancing our capabilities and, ultimately, improving patients’ lives.

Learn More